Clinical Trial Update: Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial of prinomastat in combination with temozolomide following radiation therapy for newly diagnosed glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Prinomastat (prinomastat)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Pfizer | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED